This may help provide context for your provider conversation about expected outcomes, though genetics do not predict exact medication response or blood pressure changes
In summary, peptide molecules like semaglutide and tirzepatide have provided promising results for reducing HbA1c and reducing body weight in human phase 1 and phase 2 clinical trials
The most common side effects of GLP-1 medications include nausea and vomiting, diarrhea, constipation, abdominal pain, bloating, dizziness, and fatigue
Telehealth GLP-1 prices and policies change frequently
Consent for publication All authors have read and approved the final version of the manuscript and consent to its publication in its current form
This means that insulin is only released when blood glucose levels are elevated, thereby reducing the risk of hypoglycemia, a common concern with other diabetes medications